New Balance 9060 Triple Black (GS) Taille:40 EU - 7Y US - 198 € these sweatpants are a testament Taille:41 EU - 9.5W US - 831 €

New Balance 9060 Triple Black (GS) Taille:40 EU - 7Y US - 198 € these sweatpants are a testament Taille:41 EU - 9.5W US - 831 €

Name: New Balance 9060 Triple Black (GS) Taille:40 EU - 7Y US - 198 € these sweatpants are a testament Taille:41 EU - 9.5W US - 831 €
Brand: www.ihc-sa.com
SKU: 95243115126
Price: 132.50 USD
Availability: InStock
Rating: 4.0954 (16 reviews)

EUR132.50

EUR175.50

SKU 95243115126 · ★ 4.1

Pay in 4 interest-free payments of $33.12 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Nov 10 - Nov 15

Harbor notes

Description

New Balance 9060 Triple Black (GS) Taille:40 EU 7Y US 198 € these sweatpants are a testament Taille:41 EU 9.5W US 831 € these sweatpants are a testament to the brand's commitment to quality an essential addition to any sneaker enthusiast's collection SKU : GC9060BB Release date : 2025 03 08

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy

Frequently Asked Questions for New Balance 9060 Triple Black (GS) Taille:40 EU - 7Y US - 198 € these sweatpants are a testament Taille:41 EU - 9.5W US - 831 €

What should I check when product images are described as illustrative?

Do not infer functionality from a decorative presentation element. Avoid treating staged context as part of the purchase.

What should I record if a purchase-related problem happens only sometimes?

Describe how the issue affects your intended use when it occurs. Use the observed sequence to explain the uncertainty accurately.

How can I request another review of an unresolved support issue?

Distinguish disagreement with a decision from a missing factual explanation. Focus the request on the specific unresolved issue and relevant evidence.